To enable smooth clinical operations & improve clinical trial data quality, AccelCTMS Plus has prebuilt Risk-based monitoring capabilities where clinical study sponsors can define a comprehensive set of Key Risk Indicators (KRIs) to identify potential study data factors that will require risk management, from trial planning through analytics.
Our solution can identify risk areas for a drug, and adjust for it, based on the results per trial. It can then rollup those results and provide deeper insights on the full trial risk at the program level.